|
ALBINO D.-BRIZZOLARA A.-MORETTI S.-FALUGI C.-MIRISOLA V.-SCARUFFI
P.-DI CANDIA M.-TRUINI M.-COCO S.-BONASSI S.-TONINI G.P.
Gene expression profiling identifies eleven DNA repair genes down
regulated during mouse neural crest cell migration.
Int. J. Dev. Biol. 55:65/72, 2011
PubMed Abstract
BARONE M.V.-ZANZI D.-MAGLIO M.-NANAYAKKARA M.-SANTAGATA S.-LANIA
G.-MIELE E.-RIBECCO M.-MAURANO F.-AURICCHIO R.-GIANFRANI C.-
FERRINI S.-TRONCONE R.-AURICCHIO S.
Gliadin mediated proliferation and innate immune activation in
celiac disease are due to alterations in vesicular trafficking.
PLoS One 6(2):e17039;1/e17039;12, 2011
PubMed Abstract
COLOMBO M.-CUTRONA G.-REVERBERI D.-FABRIS S.-NERI A.-FABBI M.-
QUINTANA G.-QUARTA G.-GHIOTTO F.-FAIS F.-FERRARINI M.
Intraclonal cell expansion and selection driven by B cell receptor
in chronic lymphocytic leukemia.
Mol. Med. 17(7/8):834/839, 2011
PubMed Abstract
DEL GROSSO F.-COCO S.-SCARUFFI P.-STIGLIANI S.-VALDORA F.-BENELLI
R.-SALVI S.-BOCCARDO S.-TRUINI M.-CROCE M.-FERRINI S.-LONGO L.-
TONINI G.P.
Role of CXCL13/CXCR5 crosstalk between malignant neuroblastoma
cells and Schwannian stromal cells in neuroblastic tumors.
Mol. Cancer Res. 9(7):815/823, 2011
PubMed Abstract
GIANNONI P.-SCAGLIONE S.-QUARTO R.-NARCISI R.-PARODI Ma.-BALLEARI
E.-BARBIERI F.-PATTAROZZI A.-FLORIO T.-FERRINI S.-CORTE G.-DE
TOTERO D.
An interaction between hepatocyte growth factor and its receptor
(c/MET) prolongs the survival of chronic lymphocytic leukemic
cells through STAT3 phosphorylation: a potential role of
mesenchymal cells in the disease.
Haematologica 96(7):1015/1023, 2011
PubMed Abstract
MAIO M.-NICOLAY H.-ASCIERTO P.-BELARDELLI F.-CAMERINI R.-COLOMBO
M.P.-QUEIROLO P.-RIDOLFI R.-RUSSO V.-FONSATTI E.-NIBIT-PARMIANI G.-
FERRINI S.
Eighth annual meeting of the Italian network for tumor biotherapy
(NIBIT), Siena, October 7/9, 2010.
Cancer Immunol. Immunother. 60:901/907, 2011
PubMed Abstract
MEAZZA R.-AZZARONE B.-ORENGO A.M.-FERRINI S.
Role of common gamma chain cytokines in NK cell development and
function: perspectives for immunotherapy.
J. Biomed. Biotechnol. 2011:861920;1/861920;16, 2011
PubMed Abstract
MICCICHE' F.-DA RIVA L.-FABBI M.-PILOTTI S.-MONDELLINI P.-FERRINI
S.-CANEVARI S.-PIEROTTI M.-BONGARZONE I.
Activated leukocyte cell adhesion molecule expression and shedding
in thyroid tumors.
PLoS One 6(2):e17141;1/e17141;9, 2011
PubMed Abstract
ROTONDO R.-BERTOLOTTO M.-BARISIONE G.-ASTIGIANO S.-MANDRUZZATO S.-
OTTONELLO L.-DALLEGRI F.-BRONTE V.-FERRINI S.-BARBIERI O.
Exocytosis of azurophil and arginase 1 containing granules by
activated polymorphonuclear neutrophils is required to inhibit T
lymphocyte proliferation.
J. Leukoc. Biol. 89:721/727, 2011
PubMed Abstract
CORRIAS M.-GAMBINI C.-GREGORIO A.-CROCE M.-BARISIONE G.-COSSU C.-
ROSSELLO A.-FERRINI S.-FABBI M.
Different subcellular localization of ALCAM molecules in
neuroblastoma: association with relapse.
Cell. Oncol. 32:77/86, 2010
PubMed Abstract
DE TOTERO D.-CAPAIA M.-FABBI M.-CROCE M.-MEAZZA R.-CUTRONA G.-ZUPO
S.-LOIACONO F.-TRUINI M.-FERRARINI M.-FERRINI S.
Heterogeneous expression and function of IL/21R and susceptibility
to IL/21 mediated apoptosis in follicular lymphoma cells.
Exp. Hematol. 38:373/383, 2010
PubMed Abstract
FONTANA A.-VIALE M.-GUERNELLI S.-GASBARRI C.-RIZZATO E.-MACCAGNO
M.-PETRILLO G.-AIELLO C.-FERRINI S.-SPINELLI D.
Strategies for improving the water solubility of new antitumour
nitronaphthylbutadiene derivatives.
Org. Biomol. Chem. 8:5674/5681, 2010
PubMed Abstract
GHEDINI G.-CIRAVOLO V.-TORTORETO M.-GIUFFRE' S.-BIANCHI F.-
CAMPIGLIO M.-MORTARINO M.-FIGINI M.-COLIVA A.-CARCANGIU M.-
ZAMBETTI M.-PIAZZA T.-FERRINI S.-MENARD S.-TAGLIABUE E.-PUPA S.
Shed HER2 extracellular domain in HER2 mediated tumor growth and
in Trastuzumab susceptibility.
J. Cell. Physiol. 225:256/265, 2010
PubMed Abstract
LIPNIK K.-NASCHBERGER E.-GONIN LAURENT N.-KODAJOVA P.-PETZNEK H.-
RUNGALDIER S.-ASTIGIANO S.-FERRINI S.-STURZL M.-HOHENADL C.
Interferon gamma induced human guanylate binding protein 1
inhibits mammary tumor growth in mice.
Mol. Med. 16(5/6):177/187, 2010
PubMed Abstract
NUTI E.-CASALINI F.-AVRAMOVA S.-SANTAMARIA S.-FABBI M.-FERRINI S.-
MARINELLI L.-LA PIETRA V.-LIMONGELLI V.-NOVELLINO E.-CERCIGNANI G.-
ORLANDINI E.-NENCETTI S.-ROSSELLO A.
Potent arylsulfonamide inhibitors of tumor necrosis factor alpha
converting enzyme able to reduce activated leukocyte cell adhesion
molecule shedding in cancer cell models.
J. Med. Chem. 53:2622/2635, 2010
PubMed Abstract
ORENGO A.M.-FABBI M.-MIGLIETTA L.-ANDREANI C.-BRUZZONE M.-PUPPO A.-
CRISTOFORONI P.-CENTURIONI M.G.-GUALCO M.-SALVI S.-BOCCARDO S.-
TRUINI M.-PIAZZA T.-CANEVARI S.-MEZZANZANICA D.-FERRINI S.
Interleukin (IL)/18, a biomarker of human ovarian carcinoma, is
predominantly released as biologically inactive precursor.
Int. J. Cancer 129:1116/1125, 2011 - Epub Nov 8, 2010
PubMed Abstract
SEKKAK H.-MOJAHIDI S.-RAKIB E.M.-ABOURICHA S.-KERBAL A.-AIELLO C.-
VIALE M.
Synthesis and antiproliferative evaluation of
spirothiadiazolopyridazine derivatives.
Lett. Drug Des. Discov. 7:743/746, 2010
AIROLDI I.-DI CARLO E.-COCCO C.-CACI E.-CILLI M.-SORRENTINO C.-
SOZZI G.-FERRINI S.-ROSINI S.-BERTOLINI G.-TRUINI M.-GROSSI F.-
GALIETTA L.-RIBATTI D.-PISTOIA V.
IL/12 can target human lung adenocarcinoma cells and normal
bronchial epithelial cells surrounding tumor lesions.
PLoS One 4:e6119;1/e6119;11, 2009
PubMed Abstract
BAIO G.-FABBI M.-SALVI S.-DE TOTERO D.-TRUINI M.-FERRINI S.-
NEUMAIER C.E.
Two step in vivo tumor targeting by biotin conjugated antibodies
and superparamagnetic nanoparticles assessed by magnetic resonance
imaging at 1.5 T.
Mol. Imaging Biol. 12:305/315, 2010 - Epub Oct 6, 2009
PubMed Abstract
BARBIERI F.-PATTAROZZI A.-GATTI M.-AIELLO C.-QUINTERO A.-LUNARDI
G.-BAJETTO A.-FERRARI A.-CULLER M.-FLORIO T.
Differential efficacy of SSTR1, 2, and 5 agonists in the
inhibition of C6 glioma growth in nude mice.
Am. J. Physiol. Endocrinol. Metab. 297:E1078/E1088, 2009
PubMed Abstract
CAFAGGI S.-RUSSO E.-STEFANI R.-PARODI Br.-CAVIGLIOLI G.-SILLO G.-
BISIO A.-AIELLO C.-VIALE M.
Preparation, characterisation and preliminary antitumour activity
evaluation of a novel nanoparticulate system based on a cisplatin
hyaluronate complex and N/trimethyl chitosan.
Invest. New Drugs 29:443/455, 2011 - Epub Dec 29, 2009
PubMed Abstract
CROCE M.-CORRIAS M.-ORENGO A.M.-BRIZZOLARA A.-CARLINI B.-BORGHI M.-
RIGO V.-PISTOIA V.-FERRINI S.
Transient depletion of CD4(+) T cells augments IL/21 based
immunotherapy of disseminated neuroblastoma in syngeneic mice.
Int. J. Cancer 127:1141/1150, 2010 - Epub Dec 28, 2009
PubMed Abstract
DE GIOVANNI C.-NICOLETTI G.-PALLADINI A.-CROCI S.-LANDUZZI L.-
ANTOGNOLI A.-MURGO A.-ASTOLFI A.-FERRINI S.-FABBI M.-ORENGO A.M.-
AMICI A.-PENICHET M.-AURISICCHIO L.-IEZZI M.-MUSIANI P.-NANNI P.-
LOLLINI P.
A multi DNA preventive vaccine for p53/Neu driven cancer syndrome.
Hum. Gene Ther. 20:453/464, 2009
PubMed Abstract
GANGEMI R.-PALEARI L.-ORENGO A.M.-CESARIO A.-CHESSA L.-FERRINI S.-
RUSSO P.
Cancer stem cells: a new paradigm for understanding tumor growth
and progression and drug resistance.
Curr. Med. Chem. 16:1688/1703, 2009
PubMed Abstract
KHAWAM K.-GIRON MICHEL J.-GU Y.-PERIER A.-GIULIANI M.-CAIGNARD A.-
DEVOCELLE A.-FERRINI S.-FABBI M.-CHARPENTIER B.-LUDWIG A.-CHOUAIB
S.-AZZARONE B.-EID P.
Human renal cancer cells express a novel membrane bound
interleukin/15 that induces, in response to the soluble
interleukin/15 receptor alpha chain, epithelial to mesenchymal
transition.
Cancer Res. 69:1561/1569, 2009
PubMed Abstract
MAIO M.-NICOLAY H.-ASCIERTO P.-BELARDELLI F.-CAMERINI R.-COLOMBO
Ma.-QUEIROLO P.-RIDOLFI R.-RUSSO V.-FONSATTI E.-PARMIANI G.-NIBIT-
FERRINI S.
Sixth annual meeting of the Italian network for tumor biotherapy
(NIBIT), Siena, 16/18 October 2008.
Cancer Immunol. Immunother. 59:963/969, 2010 - Epub Mar 28, 2009
PubMed Abstract
MONTICONE M.-BIOLLO E.-FABIANO A.-FABBI M.-DAGA A.-ROMEO F.-MAFFEI
M.-MELOTTI A.-GIARETTI W.-CORTE G.-CASTAGNOLA P.
z/leucinyl/leucinyl/norleucinal induces apoptosis of human
glioblastoma tumor initiating cells by proteasome inhibition and
mitotic arrest response.
Mol. Cancer Res. 7:1822/1834, 2009
PubMed Abstract
MORABITO F.-CUTRONA G.-GENTILE M.-FABBI M.-MATIS S.-COLOMBO M.-
REVERBERI D.-MEGNA M.-SPRIANO M.-CALLEA V.-VIGNA E.-ROSSI E.-LUCIA
E.-FESTINI G.-ZUPO S.-MOLICA S.-NERI A.-FERRARINI M.
Prognostic relevance of in vitro response to cell stimulation via
surface IgD in binet stage a CLL. Letter.
Br. J. Haematol. 149:160/163, 2010 - Epub Dec 8, 2009
PubMed Abstract
MORANDI B.-MORTARA L.-CARREGA P.-CANTONI C.-COSTA G.-ACCOLLA R.-
MINGARI M.C.-FERRINI S.-MORETTA L.-FERLAZZO G.
NK cells provide helper signal for CD8+ T cells by inducing the
expression of membrane bound IL/15 on DCs.
Int. Immunol. 21:599/606, 2009
PubMed Abstract
ROTONDO R.-BARISIONE G.-MASTRACCI L.-GROSSI F.-ORENGO A.M.-COSTA
R.-TRUINI M.-FABBI M.-FERRINI S.-BARBIERI O.
IL/8 induces exocytosis of arginase 1 by neutrophil
polymorphonuclears in nonsmall cell lung cancer.
Int. J. Cancer 125:887/893, 2009
PubMed Abstract
VIALE M.-CORDAZZO C.-DE TOTERO D.-BUDRIESI R.-ROSANO C.-LEONI A.-
IOAN P.-AIELLO C.-CROCE M.-ANDREANI A.-RAMBALDI M.-RUSSO P.-
CHIARINI A.-SPINELLI D.
Inhibition of MDR1 activity and induction of apoptosis by
analogues of nifedipine and diltiazem: an in vitro analysis.
Invest. New Drugs 29:98/109, 2011 - Epub Oct 30, 2009
PubMed Abstract
ALAMA A.-VIALE M.-CILLI M.-BRUZZO C.-NOVELLI F.-TASSO B.-SPARATORE
F.
In vitro cytotoxic activity of tri/n/butyltin(IV)lupinylsulfide
hydrogen fumarate (IST/FS 35) and preliminary antitumor activity
in vivo.
Invest. New Drugs 27:124/130, 2009 - Epub Jun 19, 2008
PubMed Abstract
ARINA A.-MURILLO O.-DUBROT J.-AZPILIKUETA A.-GABARI I.-PEREZ J.-ALFARO C.-BERASAIN
C.-PRIETO J.-FERRINI S.-HERVAS S.-MELERO I.
Interleukin/15 liver gene transfer increases the number and function of
IKDCs and NK cells.
Gene Ther. 15:473/483, 2008
PubMed Abstract
CECCARELLI J.-DELFINO L.-ZAPPIA E.-CASTELLANI P.-BORGHI M.-FERRINI
S.-TOSETTI F.-RUBARTELLI A.
The redox state of the lung cancer microenvironment depends on the
levels of thioredoxin expressed by tumor cells and affects tumor
progression and response to prooxidants.
Int. J. Cancer 123:1770/1778, 2008
PubMed Abstract
CROCE M.-MEAZZA R.-ORENGO A.-FABBI M.-BORGHI M.-RIBATTI D.-NICO B.-
CARLINI B.-PISTOIA V.-CORRIAS M.-FERRINI S.
Immunotherapy of neuroblastoma by an interleukin/21 secreting cell
vaccine involves survivin as antigen.
Cancer Immunol. Immunother. 57:1625/1634, 2008
PubMed Abstract
CUTRONA G.-COLOMBO M.-MATIS S.-FABBI M.-SPRIANO M.-CALLEA V.-VIGNA
E.-GENTILE M.-ZUPO S.-CHIORAZZI N.-MORABITO F.-FERRARINI M.
Clonal heterogeneity in chronic lymphocytic leukemia cells:
superior response to surface IgM cross linking in CD38, ZAP/70
positive cells.
Haematologica 93:413/422, 2008
PubMed Abstract
DE LERMA BARBARO A.-DE AMBROSIS A.-BANELLI B.-LI PIRA G.-ARESU O.-
ROMANI M.-FERRINI S.-ACCOLLA R.
Methylation of CIITA promoter IV causes loss of HLA/II
inducibility by IFN(gamma) in promyelocytic cells.
Int. Immunol. 20:1457/1466, 2008
PubMed Abstract
FENOGLIO C.-GROSSO A.-PETRILLO G.-BONCOMPAGNI E.-AIELLO C.-
CORDAZZO C.-SPINELLI D.-OGNIO E.-MARIGGIO' M.-CASSANO A.-VIALE M.
A histochemical approach to the evaluation of the in vivo
cytotoxicity of the nitrobutadienes
(1E,3E)/1,4/bis(1/naphthyl)/2,3/dinitro/1,3/butadiene and methyl
(2Z,4E)/2/methylsulfanyl/5/(1/naphtyl)/4/nitro/2,4/pentadienoate
in mice liver and kidney.
Anticancer Res. 28:813/823, 2008
PubMed Abstract
GANGEMI R.M.-GRIFFERO F.-MARUBBI D.-PERERA M.-CAPRA M.C.-MALATESTA
P.-RAVETTI G.-ZONA G.-DAGA A.-CORTE G.
SOX2 silencing in glioblastoma tumor initiating cells causes stop
of proliferation and loss of tumorigenicity.
Stem Cells 27:40/48, 2009 - Epub Oct 23, 2008
PubMed Abstract
GIULIANI M.-GIRON MICHEL J.-NEGRINI S.-VACCA P.-DURALI D.-CAIGNARD
A.-LE BOUSSE C.-CHOUAIB S.-DEVOCELLE A.-BAHRI R.-DURRBACH A.-
TAOUFIK Y.-FERRINI S.-CROCE M.-MINGARI M.C.-MORETTA L.-AZZARONE B.
Generation of a novel regulatory NK cell subset from peripheral
blood CD34+ progenitors promoted by membrane bound IL/15.
PLoS ONE 3:e2241;1/e2241;16, 2008
PubMed Abstract
MEZZANZANICA D.-FABBI M.-BAGNOLI M.-STAURENGO S.-LOSA M.-BALLADORE
E.-ALBERTI P.-LUSA L.-DITTO A.-FERRINI S.-PIEROTTI M.-BARBARESCHI
M.-PILOTTI S.-CANEVARI S.
Subcellular localization of activated leukocyte cell adhesion
molecule is a molecular predictor of survival in ovarian carcinoma
patients.
Clin. Cancer Res. 14:1726/1733, 2008
PubMed Abstract
NEUMAIER C.-BAIO G.-FERRINI S.-CORTE G.-DAGA A.
MR and iron magnetic nanoparticles. Imaging opportunities in
preclinical and translational research.
Tumori 94:226/233, 2008
ROTONDO R.-MASTRACCI L.-PIAZZA T.-BARISIONE G.-FABBI M.-CASSANELLO
M.-COSTA R.-MORANDI B.-ASTIGIANO S.-CESARIO A.-SORMANI M.-FERLAZZO
G.-GROSSI F.-RATTO G.B.-FERRINI S.-FRUMENTO G.
Arginase 2 is expressed by human lung cancer, but it neither
induces immune suppression, nor affects disease progression.
Int. J. Cancer 123:1108/1116, 2008
PubMed Abstract
VIALE M.-CORDAZZO C.-COSIMELLI B.-DE TOTERO D.-CASTAGNOLA P.-
AIELLO C.-SEVERI E.-PETRILLO G.-CIANFRIGLIA M.-SPINELLI D.
Inhibition of MDR1 activity in vitro by a novel class of diltiazem
analogues: toward new candidates.
J. Med. Chem. 52:259/266, 2009 - Epub Dec 18, 2008
PubMed Abstract
VIALE M.-PETRILLO G.-MACCAGNO M.-CASTAGNOLA P.-AIELLO C.-CORDAZZO
C.-MARIGGIO' M.-JADHAV S.-BIANCHI L.-LETO G.-RIZZATO E.-POGGI A.-
SPINELLI D.
Sensitivity of different resistant tumour cell lines to the two
novel compounds (2Z,4E)/2/methylsulfanyl/5/(1/naphthyl)/4/nitro/2,4
/pentadienoate and (1E,3E)/1,4/bis(2/naphthyl)/2,3/dinitro/1,3/buta
diene.
Eur. J. Pharmacol. 588:47/51, 2008
PubMed Abstract
CAFAGGI S.-RUSSO E.-STEFANI R.-LEARDI R.-CAVIGLIOLI G.-PARODI Br.-BIGNARDI G.-DE TOTERO D.-AIELLO C.-VIALE M.
Preparation and evaluation of nanoparticles made of chitosan or N/trimethyl chitosan and a cisplatin/alginate complex.
J. Control. Release 121:110/123, 2007
PubMed Abstract
DAGA A.-ORENGO A.-GANGEMI R.-MARUBBI D.-PERERA M.-COMES A.-FERRINI S.-CORTE G.
Glioma immunotherapy by IL/21 gene modified cell or by recombinant IL/21 involves antibody responses.
Int. J. Cancer 121:1756/1763, 2007
PubMed Abstract
DE GIOVANNI C.-CROCI S.-NICOLETTI G.-LANDUZZI L.-PALLADINI A.-PANNELLINI T.-BORGIA L.-IEZZI M.-DI CARLO E.-ORENGO A.-KENNEDY R.-
LOLLINI P.-NANNI P.-MUSIANI P.
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis.
Int. J. Cancer 121:88/94, 2007
PubMed Abstract
DE TOTERO D.-MEAZZA R.-CAPAIA M.-FABBI M.-AZZARONE B.-BALLEARI E.-GOBBI M.-CUTRONA
G.-FERRARINI M.-FERRINI S.
The opposite effects of IL/15 and IL/21 on CLL B cells correlate with
differential activation of the JAK/STAT and ERK1/2 pathways.
Blood 111:517/524, 2008 - Epub Oct 15, 2007
PubMed Abstract
DI CARLO E.-DE TOTERO D.-PIAZZA T.-FABBI M.-FERRINI S.
Role of IL/21 in immune/regulation and tumor immunotherapy.
Cancer Immunol. Immunother. 56:1323/1334, 2007
PubMed Abstract
NANNI P.-NICOLETTI G.-PALLADINI A.-CROCI S.-MURGO A.-ANTOGNOLI A.-LANDUZZI
L.-FABBI M.-FERRINI S.-MUSIANI P.-IEZZI M.-DE GIOVANNI C.-LOLLINI P.
Antimetastatic activity of a preventive cancer vaccine.
Cancer Res. 67:11037/11044, 2007
PubMed Abstract
PALMIERI G.-MONTELLA L.-AIELLO C.-BARBIERI F.-DI VIZIO D.-SCHULZ S.-BENINATI S.-BUDILLON A.-CARAGLIA M.-INSABATO L.-FLORIO T.
Somatostatin analogues, a series of tissue transglutaminase inducers, as a new tool for therapy of mesenchimal tumors of the
gastrointestinal tract.
Amino Acids 32:395/400, 2007
PubMed Abstract
PETRILLO G.-FENOGLIO C.-OGNIO E.-AIELLO C.-SPINELLI D.-MARIGGIO' M.-MACCAGNO M.-MORGANTI S.-CORDAZZO C.-VIALE M.
Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity.
Invest. New Drugs 25:535/544, 2007
PubMed Abstract
PETRILLO G.-MARIGGIO' M.-AIELLO C.-CORDAZZO C.-FENOGLIO C.-MORGANTI S.-CROCE
M.-RIZZATO E.-SPINELLI D.-MACCAGNO M.-BIANCHI L.-PREVOSTO C.-TAVANI C.-VIALE M.
Design, synthesis, and in vitro evaluation of new naphthylnitrobutadienes
with potential antiproliferative activity: toward a structure/activity
correlation.
Bioorg. Med. Chem. 16:240/247, 2008 - Epub Sep 26, 2007
PubMed Abstract
ROSSO O.-PIAZZA T.-BONGARZONE I.-ROSSELLO A.-MEZZANZANICA D.-CANEVARI S.-ORENGO
A.-PUPPO A.-FERRINI S.-FABBI M.
The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in
motility of ovarian carcinoma cells.
Mol. Cancer Res. 5:1246/1253, 2007
PubMed Abstract
VIALE M.-PETRILLO G.-AIELLO C.-FENOGLIO C.-CORDAZZO C.-MARIGGIO'M.-CASSANO A.-PREVOSTO C.-OGNIO E.-MACCAGNO M.-BIANCHI L.-VACCARONE R.-RIZZATO E.-SPINELLI D.
Synthesis, in vitro activity and in vivo toxicity of the new 2,3-dinitrobutadiene derivative (1E,3E)-1,4-bis(2-naphthyl)-2,3-dinitro-1,3-butadiene.
Pharmacol. Res. 56:318/328, 2007
PubMed Abstract
BAIO G.-FABBI M.-DE TOTERO D.-FERRINI S.-CILLI M.-DERCHI L.-NEUMAIER C.
Magnetic resonance imaging at 1.5T with immunospecific contrast agent in vitro and in vivo in a xenotransplant model.
Magn. Reson. Mather. Phy. 19:313/320, 2006
PubMed Abstract
COMES A.-ROSSO O.-ORENGO A.-DI CARLO E.-SORRENTINO C.-MEAZZA R.-PIAZZA T.-VALZASINA B.-NANNI P.-COLOMBO M.-FERRINI S.
CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL/21 secreting cellular vaccine.
J. Immunol. 176:1750/1758, 2006
PubMed Abstract
DE AMBROSIS A.-CASCIANO I.-CROCE M.-PAGNAN G.-RADIC L.-BANELLI B.-DI VINCI A.-ALLEMANNI G.-TONINI G.P.-PONZONI M.-ROMANI M.-FERRINI S.
An interferon sensitive response element is involved in constitutive caspase/8 gene expression in neuroblastoma cells.
Int. J. Cancer 120:39/47, 2006
PubMed Abstract
DE TOTERO D.-MEAZZA R.-ZUPO S.-CUTRONA G.-MATIS S.-COLOMBO M.-BALLEARI E.-PIERRI I.-FABBI M.-CAPAIA M.-AZZARONE B.-GOBBI M.-
FERRARINI M.-FERRINI S.
Interleukin/21 receptor (IL/21R) is up regulated by CD40 triggering and mediates preapoptotic signals in chronic lymphocytic leukemia B cells.
Blood 107:3708/3715, 2006
PubMed Abstract
FRUMENTO G.-PIAZZA T.-DI CARLO E.-FERRINI S.
Targeting tumor related immunosuppression for cancer immunotherapy.
Endocr. Metab. Immune Disord. Drug Targets 6:233/237, 2006
PubMed Abstract
GANGEMI R.-DAGA A.-MUZIO L.-MARUBBI D.-COCOZZA S.-PERERA M.-VERARDO S.-BORDO D.-GRIFFERO F.-CAPRA M.-MALLAMACI A.-CORTE G.
Effects of Emx2 inactivation on the gene expression profile of neural precursors.
Eur. J. Neurosci. 23:325/334, 2006
PubMed Abstract
MORTARA L.-CASTELLANI P.-MEAZZA R.-TOSI G.-DE LERMA A.-PROCOPIO F.-COMES A.-ZARDI L.-FERRINI S.-ACCOLLA R.
CIITA induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor
microenvironment, tumor rejection, and specific antitumor memory.
Clin. Cancer Res. 12:3435/3443, 2006
PubMed Abstract
OGNIO E.-CHIAVARINA B.-PETERKA M.-MARIGGIO' M.-VIALE M.
Study of feasibility of the treatment with procainamide hydrochloride and cisplatin in pregnant mice.
Chem. Biol. Interact. 164:232/240, 2006
PubMed Abstract
Per le pubblicazioni 2000-2005 del personale della struttura vedere gli
elenchi generali.
|
Presentazione della struttura